Cardiologist Says FDA Is 'Late to the Show' on Teen Vaping Crisis

February 12, 2019

By Carlo Versano

The shocking rise in teen vaping is a public health crisis that the FDA has been slow to address, according to a nationally recognized cardiologist.

Dr. Kevin Campbell, who is also CEO of Pace Mate, a digital cardiac monitoring service, said the recent study from the CDC that linked vaping to a spike in teen tobacco use shows that more serious steps need to be take. The first step? Get rid of the flavored nicotine "pods," which Campbell said are acting as a gateway for teenage beginner vapers to get hooked on nicotine.

"We don't know the long-term health effects yet," Campbell said. "I can't emphasize that enough."

While popular vape products are unarguably "healthier" than combustible cigarettes, they still involve the delivery of an addictive drug (nicotine), that is known to do damage to the heart and blood vessels. And there is not enough data on the additives and preservatives that go into the pods.

"They may be doing deleterious things to our bodies as well," Campbell said.

One in five American high schoolers now vapes, according to the CDC, which is enough to cause alarm at the FDA. That agency recently announced a crackdown on vaping companies that market to teens, but that's not enough, in Campbell's opinion.

"I think the FDA is a little bit late to the show here," he said. It's going to require a national education program ー think D.A.R.E. for a new era ー that explains the unknowns and risks involved in vaping. "We need to get ahead of it," Campbell said.

For full interview click here.